Home NDC 51662-1323 GLUCAG0N
Product NDC 51662-1323
11-digit product format 516621323
Labeler code 51662
Product ID 51662-1323_ef6d3da2-6bf2-fbc7-e053-2a95a90a74cd
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name glucagon kit
Dosage form KIT
Route INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Labeler HF Acquisition Co LLC, DBA HealthFirst
Application NDA020298
Marketing category NDA
Marketing start 2018-10-20
Marketing end 0000-00-00
Active strength 0
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 18 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 51662-1323-1 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 51662-1323-1 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 51662-1323-1 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 51662-1323-1 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 51662-1323-1 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 51662-1323-1 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 51662-1323-1 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 51662-1323-1 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 51662-1323-1 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020298-001 ALOPRIM ALLOPURINOL SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N020298-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N020298-001 ALOPRIM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RLD, RS 1996-05-17 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 51662-1323-1 GLUCAG0N 1 in 1 KIT KIT 1 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 51662-1323 GLUCAG0N (GLUCAGON KIT) KIT [HF ACQUISITION CO LLC, DBA HEALTHFIRST] 4 Legacy NDC, 1 package rows 20221211_789ab694-3ad8-a122-e053-2991aa0a9ab3.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Aloprim ALLOPURINOL Mylan Institutional LLC 10cc918f-aa44-415b-932d-2404695ac449 2022-02-18 Warnings, Adverse reactions Exact identifier application applno (NDA): 020298 application number: NDA020298
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 51662-1323-1 51662132301 1 KIT in 1 KIT (51662-1323-1) * 1 mL in 1 VIAL * 1 mL in 1 SYRINGE 1 kit 2018-10-20 0000-00-00 No No Current